AB Corporate Financials
| EYEG Etf | USD 35.00 0.01 0.03% |
Net Expense Ratio 0.003 |
EYEG |
The data published in AB Corporate's official financial statements typically reflect AB Corporate's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving AB Corporate's quantitative information. For example, before you start analyzing numbers published by EYEG accountants, it's essential to understand AB Corporate's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
AB Corporate Etf Summary
AB Corporate competes with VanEck Vectors, Valued Advisers, Xtrackers California, Principal Exchange, and Vanguard ESG. EyeGate Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and nervous system in the United States. Eyegate Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Waltham, Massachusetts. Eyegate Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.| Instrument | USA Etf View All |
| Exchange | NASDAQ Exchange |
| ISIN | US49721T1016 |
| CUSIP | 00039J863 |
| Region | Global |
| Investment Issuer | AllianceBernstein |
| Location | New York; U.S.A |
| Business Address | 271 Waverley Oaks |
| Etf Family | Healthcare |
| Fund Category | Corporate |
| Portfolio Concentration | Investment Grade |
| Benchmark | Dow Jones Industrial |
| Website | www.eyegatepharma.com |
| Phone | 781 788 8869 |
| Currency | USD - US Dollar |
AB Corporate Key Financial Ratios
EYEG Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AB Corporate's current stock value. Our valuation model uses many indicators to compare AB Corporate value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AB Corporate competition to find correlations between indicators driving AB Corporate's intrinsic value. More Info.AB Corporate Bond is rated # 2 ETF in price to earning as compared to similar ETFs. It also is rated # 2 ETF in price to book as compared to similar ETFs . Comparative valuation analysis is a catch-all technique that is used if you cannot value AB Corporate by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.AB Corporate Bond Systematic Risk
AB Corporate's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AB Corporate volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on AB Corporate Bond correlated with the market. If Beta is less than 0 AB Corporate generally moves in the opposite direction as compared to the market. If AB Corporate Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AB Corporate Bond is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AB Corporate is generally in the same direction as the market. If Beta > 1 AB Corporate moves generally in the same direction as, but more than the movement of the benchmark.
About AB Corporate Financials
What exactly are AB Corporate Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include AB Corporate's income statement, its balance sheet, and the statement of cash flows. Potential AB Corporate investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although AB Corporate investors may use each financial statement separately, they are all related. The changes in AB Corporate's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AB Corporate's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.AB Corporate Thematic Clasifications
AB Corporate Bond is part of several thematic ideas from Investment Grade ETFs to Corporate ETFs. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasAB Corporate January 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of AB Corporate help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AB Corporate Bond. We use our internally-developed statistical techniques to arrive at the intrinsic value of AB Corporate Bond based on widely used predictive technical indicators. In general, we focus on analyzing EYEG Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AB Corporate's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 1.73 | |||
| Value At Risk | (0.65) | |||
| Potential Upside | 0.7332 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in AB Corporate Bond. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
The market value of AB Corporate Bond is measured differently than its book value, which is the value of EYEG that is recorded on the company's balance sheet. Investors also form their own opinion of AB Corporate's value that differs from its market value or its book value, called intrinsic value, which is AB Corporate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AB Corporate's market value can be influenced by many factors that don't directly affect AB Corporate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AB Corporate's value and its price as these two are different measures arrived at by different means. Investors typically determine if AB Corporate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AB Corporate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.